Vesta Aesthetics operates in compliance with FDA regulations governing 503A patient-specific compounding and does not stock, resell, or distribute medications outside this framework
But before you throw in the towel (or use it to mop up tears of frustration), we've got some news that'll make you sit up straighter than your mom telling you to fix your posture
Continue below or switch doors anytime
The FLOW trial is not the only to observe renal benefits with semaglutide
Oral tirzepatide Oral tirzepatide is in advanced development and early data suggests it may achieve weight loss results closer to injectable tirzepatide than oral semaglutide achieves relative to its injectable counterpart
However, due to the paucity of data, observed differences in efficacy cannot be generalized to patients affected by overweight (that is, with BMI 2730 kg m 2 ) or to those with a BMI 40 kg m 2